PAM II OF COVINGTON
1. Target Overview & Investment Thesis
PAM II OF COVINGTON is a 31-bed community hospital in ST. TAMMANY PARISH, LA with $20.2M in net patient revenue and a 4.9% operating margin. The hospital serves a payer mix of 62.5% Medicare, 0.0% Medicaid, and 37.5% commercial.
Thesis: Turnaround. Our ML models identify $1.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 4.9% to 12.3% (+736bps).
| Net Revenue HCRIS | $20.2M |
| Current EBITDA COMPUTED | $997K |
| Operating Margin COMPUTED | 4.9% |
| Occupancy HCRIS | 65.1% |
| Revenue / Bed COMPUTED | $652K |
| Net-to-Gross HCRIS | 33.8% |
| Distress Probability ML | nan% |
2. Market Context & Competitive Position
LA has 212 Medicare-certified hospitals with a median operating margin of -3.5%. The target's margin of 4.9% places it above the state median. Among 132 size-comparable peers (16-62 beds), the median margin is -3.3%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (16-62), prioritizing same-state peers. 132 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| PAM II OF COVINGTON (Target) | LA | 31 | $20.2M | 4.9% |
| UNIVERSITY HOSPITAL & CLINICS | LA | 52 | $158.9M | -33.4% |
| NEW ORLEANS EAST HOSPITAL | LA | 60 | $77.6M | -29.7% |
| OCHSNER BAYOU LLC | LA | 25 | $76.5M | -0.9% |
| OUR LADY OF THE ANGELS HOSPITA | LA | 36 | $76.2M | -4.9% |
| CENTRAL LOUISIANA SURGICAL HOS | LA | 24 | $69.1M | 7.7% |
| ABBEVILLE GENERAL HOSPITAL | LA | 44 | $68.5M | 3.4% |
| ST. CHARLES PARISH HOSPITAL | LA | 27 | $64.0M | -5.1% |
| AVALA | LA | 21 | $64.0M | 7.4% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $424K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $404K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $400K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $246K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $13K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $997K |
| + RCM Uplift | +$1.5M |
| Pro Forma EBITDA | $2.5M |
| Current Margin | 4.9% |
| Pro Forma Margin | 12.3% |
| WC Released (1x) | $775K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $1.5M | $21.4M | 13.98x | 69.5% |
| Base (11x exit) | 10.0x | 11.0x | $1.5M | $24.1M | 15.71x | 73.5% |
| Bull Case | 9.0x | 11.0x | $1.4M | $29.5M | 21.37x | 84.5% |
| Bull (12x exit) | 9.0x | 12.0x | $1.4M | $32.6M | 23.61x | 88.2% |
| Bear Case | 11.0x | 10.0x | $1.7M | $13.5M | 8.01x | 51.6% |
| Bear (11x exit) | 11.0x | 11.0x | $1.7M | $15.4M | 9.14x | 55.6% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Heavy Medicare dependence | Medicare comprises 62.5% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 132 hospitals with 16-62 beds
- Same-state prioritization (n=133)
- Comp margins: P25=-19.6% / P50=-3.3% / P75=5.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.